Alkylating agents: all 3,295 studies that test it

Page 32 of 33. Open to participants first (456), then studies with results posted, then the rest; newest registration first within each.

• Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00004158Phase 1/2
• Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004145Phase 2
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00004141Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerCompletedNCT00004135Phase 2
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
• Temozolomide in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004113Phase 2
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedNCT00004112Phase 3
• Temozolomide in Treating Patients With Mycosis Fungoides or Sezary SyndromeTerminatedNCT00004106Phase 2
• Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular CancerCompletedNCT00004077Phase 2
• O6-benzylguanine And Carmustine in Treating Patients With Multiple MyelomaCompletedNCT00004072Phase 2
• Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain TumorCompletedNCT00004068Phase 2
• Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00004056Phase 1
• Carmustine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004028Phase 1
• Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's DiseaseCompletedNCT00004010Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast CancerCompletedNCT00003972Phase 3
• Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple MyelomaCompletedNCT00003954Phase 1/2
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell CancerCompletedNCT00003941Phase 3
• Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerCompletedNCT00003927Phase 1
• Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsTerminatedNCT00003926Phase 1
• Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00003899Phase 1
• Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic LeukemiaCompletedNCT00003870Phase 2
• Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid LeukemiaCompletedNCT00003868Phase 2
• Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNSCompletedNCT00003859Phase 3
• Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsCompletedNCT00003846Phase 2
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00003829Phase 2
• Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or LegCompletedNCT00003789Phase 3
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic LeukemiaCompletedNCT00003783Phase 2
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS TumorsCompletedNCT00003765Phase 1
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003764Phase 3
• Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood CancersCompletedNCT00003754Phase 2
• Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic MelanomaStatus unknownNCT00003747Phase 1
• Temozolomide in Treating Patients With Recurrent Oligodendroglial TumorsCompletedNCT00003731Phase 2
• Temozolomide in Treating Patients With Advanced Soft Tissue SarcomaStatus unknownNCT00003718Phase 2
• Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid TumorsCompletedNCT00003710Phase 1
• Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00003708Phase 1
• Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung CancerStatus unknownNCT00003696Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic Kidney CancerCompletedNCT00003683Phase 2
• Combination Chemotherapy in Treating Women With Breast CancerStatus unknownNCT00003679Phase 3
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaCompletedNCT00003671Phase 2
• Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaCompletedNCT00003667Phase 2
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell CancersCompletedNCT00003658Phase 2
• High-dose ICE With AmifostineCompletedNCT00003657Phase 2
• Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003647Phase 3
• Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's LymphomaStatus unknownNCT00003639Phase 3
• Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the StomachStatus unknownNCT00003617Phase 3
• O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell LymphomaTerminatedNCT00003613Phase 1
• Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00003606Phase 3
• Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's LymphomaWithdrawnNCT00003605Phase 2
• Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple MyelomaStatus unknownNCT00003603Phase 3
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003597Phase 1
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerCompletedNCT00003596Phase 3
• Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003575Phase 2
• Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNCT00003567Phase 1
• S9716: Combination Chemotherapy in Treating Patients With Merkel Cell CancerCompletedNCT00003549Phase 2
• Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade GliomaCompletedNCT00003467Phase 2
• Temozolomide in Treating Patients With Progressive Low-Grade GliomaCompletedNCT00003466Phase 2
• Temozolomide in Treating Patients With Anaplastic OligodendrogliomaCompletedNCT00003465Phase 2
• Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma MultiformeCompletedNCT00003464Phase 2
• Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade GliomasCompletedNCT00003463Phase 1
• Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal TumorsCompletedNCT00003462Phase 1
• Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectCompletedNCT00003425Phase 1/2
• Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma MultiformeCompletedNCT00003417Phase 1/2
• S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00003416Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerCompletedNCT00003406Phase 1/2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00003402Phase 2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003401Phase 2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003399Phase 2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00003397Phase 2
• Combination Chemotherapy in Treating Patients With AIDS-Related LymphomaCompletedNCT00003388Phase 2
• Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade GliomaCompletedNCT00003375Phase 2/3
• High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00003353Phase 2
• Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00003352Phase 2
• Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the BrainCompletedNCT00003348Phase 1
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003346Phase 2
• Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00003340Phase 2
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00003311Phase 2
• Temozolomide in Treating Patients With Recurrent Oligodendroglial TumorsCompletedNCT00003304Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian CancerCompletedNCT00003297Phase 1/2
• S9624 Ifosfamide in Treating Patients With Meningeal TumorsTerminatedNCT00003292Phase 2
• Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid TumorsCompletedNCT00003288Phase 1
• High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung CancerStatus unknownNCT00003284Phase 2
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain TumorWithdrawnNCT00003273Phase 2
• Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00003269Phase 2
• Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT00003217Phase 1
• Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00003212Phase 3
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal TumorCompletedNCT00003211Phase 2
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's LymphomaCompletedNCT00003204Phase 3
• Ifosfamide and Topotecan in Treating Patients With Refractory Solid TumorsCompletedNCT00003198Phase 1
• Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00003195Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid TumorsTerminatedNCT00003194Phase 1
• Temozolomide and Carmustine in Treating Patients With Anaplastic GliomaCompletedNCT00003176Phase 2
• High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsCompletedNCT00003173Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00003146Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord TumorsCompletedNCT00003141Phase 1
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00003136Phase 1/2
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the UterusCompletedNCT00003128Phase 3
• Surgery in Treating Children With NeuroblastomaCompletedNCT00003119Phase 3
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003116Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
• Combination Chemotherapy in Treating Children With NeuroblastomaCompletedNCT00003093Phase 3

← Alkylating agents overview